Received: 25 July 2020
Accepted: 20 May 2021
First Online: 31 May 2021
: The study protocol was approved (ethics committee number: 57ECRIES94/02/15) by the ethics research council of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences. Written informed consents were obtained from all participants. The study protocol was conducted according to the principles expressed in the Declaration of Helsinki.
: Not Applicable.
: The authors declare that they have no competing of interests. Dr. Zahra Bahadoran is a member of the editorial board of BMC Endocrine Disorders<i>.</i>